Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-11

FDA Approved: ATOVAQUONE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' generic atovaquone under an original ANDA (ANDA 210692).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atovaquone (Atovaquone)

Snippet

ORIG AP for ATOVAQUONE (ATOVAQUONE)